Brazilian aerospace company Embraer, the world’s third-largest planemaker, reported on Thursday that it delivered 62 aircraft in the third quarter of 2025, marking a 5% increase compared to the 59 deliveries during the same period last year.
The quarter saw 20 commercial aircraft delivered, up 25% year-over-year, highlighting solid demand in this segment. Embraer also handed over 41 executive jets, a figure consistent with last year’s performance. The company noted that the Phenom 300 light jet accounted for nearly half of executive jet deliveries, underscoring its continued popularity in the business aviation market.
In its defense segment, Embraer delivered one KC-390 Millennium transport aircraft, compared with two in the same quarter of 2024. Despite the lower defense deliveries, overall performance kept the company aligned with its 2025 guidance.
Embraer has projected annual deliveries of 77 to 85 commercial aircraft and 145 to 155 executive jets. So far in 2025, the planemaker has delivered 46 commercial jets and 102 executive jets, leaving it on pace to meet the lower end of its forecast. Analysts at Citi, including Andre Mazini, commented that while the figures reflect stability, they may be viewed as “lukewarm” by investors, especially given market expectations.
Investor sentiment reflected this cautious outlook. Embraer’s shares, traded in São Paulo, dropped 5.8% on Thursday, making them one of the biggest losers on Brazil’s Bovespa index, which itself slipped 1.1%.
The company is scheduled to release its third-quarter financial results on November 4, which will provide deeper insight into profitability and future demand trends. With commercial aircraft deliveries strengthening and executive jet sales steady, Embraer remains focused on navigating industry challenges while aiming to achieve its year-end targets.


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 



